Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Reviews

Exploiting Replication Stress as a Novel Therapeutic Intervention

Jeffrey C. Martin, Tamara J. Hoegel, Miranda L. Lynch, Anna Woloszynska, Thomas Melendy and Joyce E. Ohm
Jeffrey C. Martin
1Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamara J. Hoegel
2Department of Pediatric Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miranda L. Lynch
3Hauptman-Woodward Medical Research Institute, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miranda L. Lynch
Anna Woloszynska
4Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Melendy
5Department of Microbiology and Immunology, State University of New York at Buffalo, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Melendy
Joyce E. Ohm
1Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joyce E. Ohm
  • For correspondence: joyce.ohm@roswellpark.org
DOI: 10.1158/1541-7786.MCR-20-0651 Published February 2021
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Canonical activation of the ATR–CHK1 signaling pathway. In its simplest form, the ATR–CHK1 pathway consists of three main steps. The first is the generation of ssDNA gap between the MCM2–7 helicase complex and the DNA polymerase. The generation of ssDNA gap can occur on either leading or lagging strand but most often occurs on the leading strand due to the discontinuous nature of lagging strand synthesis. Then, the ssDNA is recognized and bound by the heterotrimer RPA complex which is the substrate that facilitates the binding of the ATR-interacting protein, ATRIP. ATRIP binding catalyzes the recruitment of the ATR kinase to the site of the stalled fork. ATR binding to chromatin facilitates the activation of its kinase activity. Active ATR phosphorylates several substrates including RPA2, ATR itself and, most importantly, CHK1 kinase. Once phosphorylated by ATR, CHK1 disperses throughout the nucleus, amplifying the signaling cascade. The four main objectives of this pathway are to inhibit the progression of the cell cycle, halt the firing of any late-firing replication origins, promote the initiation of replication from local dormant origins, contributing to various DNA repair pathways, while stabilizing and allowing for the restart of the stalled replication fork.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    ATR-CHK1-WEE1 role in the regulation of replication origin firing. Even in the absence of replication stress, the enzymes involved in the replication stress response work to limit the level of origin firing by directly and indirectly inhibiting the kinase activity of CDK2-cyclin E and CDC7-DBF4 (DDK). The activation of the replisome requires to main events; the binding of CDC45 and the binding of the GINS complex. Along with the MCM2–7 helicase, the complex formed between CDC45 and GINS is referred to as the CMG helicase complex (CDC45-MCM2–7-GINS helicase complex). The recruitment of CDC45 and GINS requires CDK2- and DDK-mediated phosphorylation of the MCM2–7 helicase. WEE1 mainly works to phosphorylate and deactivate the CDK2–cyclin E complex. This phosphorylation is actively removed by the APC/CDC25A phosphatase complex. Active CHK1 phosphorylates CDC25A, marking it for degradation by the proteasome, indirectly inhibiting the activity of CDK2. ATR directly phosphorylates GINS inhibiting DDK binding, hindering DDK kinase activity and limiting its ability to phosphorylate and active the replisome.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Histone recycling and replication stress. Histone recycling takes place during replication and is one of the main mechanisms that allow for epigenetic information that is carried on histones to be inherited by daughter cells upon cell division. A, Parental histones are removed ahead of the progressing replication fork and are immediately deposited into the newly synthesized strands of DNA. These are accompanied by new histones that are initially devoid of any posttranslational modifications. The methylation pattern of the parental histones is recognized and copied to new histones in a process that still remains somewhat elusive. This allows for the inheritance of epigenetic information to daughter cells and proper recapitulation of gene expression and cellular function after cell division. B, If polymerase progression is impeded by replication blockades the process of histone removal and deposition into newly synthesized DNA is decoupled. This inhibits the histone recycling process. Once the blockade is removed and replication continues, the parental histones that were removed ahead of the fork are no longer in a position to be placed into the new DNA strand. This results in the placement of long stretches of new histones that are devoid of posttranslational modifications and loss of the preexisting epigenetic information. This has the potential to dramatically alter gene expression and cellular function.

PreviousNext
Back to top
Molecular Cancer Research: 19 (2)
February 2021
Volume 19, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Exploiting Replication Stress as a Novel Therapeutic Intervention
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Exploiting Replication Stress as a Novel Therapeutic Intervention
Jeffrey C. Martin, Tamara J. Hoegel, Miranda L. Lynch, Anna Woloszynska, Thomas Melendy and Joyce E. Ohm
Mol Cancer Res February 1 2021 (19) (2) 192-206; DOI: 10.1158/1541-7786.MCR-20-0651

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Exploiting Replication Stress as a Novel Therapeutic Intervention
Jeffrey C. Martin, Tamara J. Hoegel, Miranda L. Lynch, Anna Woloszynska, Thomas Melendy and Joyce E. Ohm
Mol Cancer Res February 1 2021 (19) (2) 192-206; DOI: 10.1158/1541-7786.MCR-20-0651
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Dynamics of Eukaryotic Replication
    • Replication Stress: Sources and Responses
    • Targeting the Replication Stress Response in Cancer
    • Replication Stress in Ewing Sarcoma
    • Conclusions
    • Authors' Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • O-GlcNAc Transferase—Oncogene or Not?
  • BTK for COVID-19 Treatment
  • MEK/ERK Network as a Therapeutic Target
Show more Reviews
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement